Recently, our research group has demonstrated the utility of both WT1 and cyclin D1 in the differential diagnosis of SRBCTs on surgically-resected specimens, the former being diffusely expressed in all subtypes of RMS and the latter in EWS and NB [20,31,32,33,34,35]. The gene discussed is WT1; the disease is neuroblastoma.